Form 8-K - Current report:
SEC Accession No. 0001144204-18-036342
Filing Date
2018-06-28
Accepted
2018-06-28 16:01:32
Documents
2
Period of Report
2018-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv497547_8k.htm 8-K 20038
2 GRAPHIC image_001.jpg GRAPHIC 5687
  Complete submission text file 0001144204-18-036342.txt   29258
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 18925365
SIC: 2834 Pharmaceutical Preparations